BBVA USA Bancshares’s Allergan Inc AGN Stock Holding History

BBVA USA Bancshares’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,022	Closed	-$1.28M	–	574
2014 Q4	$1.28M	Buy	6,022 +255	+4%	+$50.7K	0.06%	246
2014 Q3	$1.03M	Sell	5,767 -6,601	-53%	-$1.1M	0.05%	273
2014 Q2	$2.09M	Sell	12,368 -1,046	-8%	-$163K	0.09%	198
2014 Q1	$1.67M	Sell	13,414 -3,240	-19%	-$395K	0.08%	209
2013 Q4	$1.85M	Sell	16,654 -3,827	-19%	-$366K	0.08%	208
2013 Q3	$1.85M	Sell	20,481 -1,445	-7%	-$130K	0.09%	203
2013 Q2	$1.85M	Buy	+21,926	New	+$2.27M	0.09%	201

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

BBVA USA Bancshares's AGN Position: Q1 2015 in Review

BBVA USA Bancshares sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 6,022 shares — an estimated $1.28M sold.

BBVA USA Bancshares first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.09M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

BBVA USA Bancshares reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
BBVA USA Bancshares sold 6,022 Allergan Inc shares in Q1 2015, an estimated $1.28M.
BBVA USA Bancshares first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
BBVA USA Bancshares's Allergan Inc position peaked at $2.09M in Q2 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BBVA USA Bancshares's 13F filing for Q1 2015, filed 6 May 2015.